EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma

Man Shu, Leilei Huang, Yu Chen, Yanxia Wang, Zhongpeng Xie, Shuhua Li, Jianwen Zhou, Lihong Wei, Tongze Fu, Bixia Liu, Honglei Chen, Kejing Tang und 1 weitere

Cancer Letters · 2024

DOI: 10.1016/j.canlet.2024.216835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Man Shu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, PR China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, DNA Methylation, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Planning Project of Guangdong Province, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

"Driver gene-negative" lung adenocarcinoma (LUAD) was of rare treatment options and a poor prognosis. Presently, for them, few biomarkers are available for stratification analysis to make appropriate treatment strategy. This study aimed to develop a DNA-methylome-based signature to realize the precise risk-stratifying. Here, an Illumina MethylationEPIC Beadchip was applied to obtain differentially methylated CpG sites (DMCs). A four-CpG-based signature, named as TLA, was successfully established, whose prognosis-predicting power was well verified in one internal (n = 78) and other external (n = 110) validation cohorts. Patients with high-risk scores had shorter overall survival (OS) in all cohorts [hazard ratio (HR): 11.79, 5.16 and 2.99, respectively]. Additionally, it can effectively divide patients into low-risk and high-risk groups, with significantly different OS in the diverse subgroups stratified by the standard clinical parameters. As an independent prognostic factor, TLA may assist in improving the nomogram's 5-year OS-predicting ability (AUC 0.756, 95% CI:0.695-0.816), superior to TNM alone (AUC 0.644, 95% CI: 0.590-0.698). Additionally, the relationship of TLA-related genes, TAC1, LHX9, and ALX1, with prognosis and tumour invasion made them serve as potential therapy targets for driver gene-negative LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungDNA MethylationLung NeoplasmsBiomarkers, TumorHumansMaleFemalePrognosisMiddle AgedCpG IslandsAgedGene Expression Regulation, NeoplasticEpigenomeNomograms

Stichwörter der Autor:innen

DNA methylationDriver geneLung adenocarcinomaPrognosisTherapeutic target

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, PR China.
  • Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, PR China; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, G…
  • Molecular Diagnosis and Gene Test Centre, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, PR China.
  • Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, PR China; Molecular Diagnosis and Gene Test Centre, The First Affiliated Hospital of Sun Yat-Sen University, Guangz…
  • Department of Pathology, School of Basic Medical Science, Wuhan University, Wuhan, Hubei, PR China. Electronic address: hl-chen@whu.edu.cn.
  • Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China; Institute of Pulmonary Diseases, Sun Yat-sen University, Guangzhou, PR China. Electronic addr…

Förderung

  • Science and Technology Planning Project of Guangdong Province
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Zitieren

APA

Shu, M., Huang, L., Chen, Y., Wang, Y., Xie, Z., Li, S., Zhou, J., Wei, L., Fu, T., Liu, B., Chen, H., Tang, K., & Ke, Z. (2024). Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216835

Vancouver

Shu M, Huang L, Chen Y, Wang Y, Xie Z, Li S, et al. Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216835

BibTeX
@article{Shu2024,
  author = {Shu, Man and Huang, Leilei and Chen, Yu and Wang, Yanxia and Xie, Zhongpeng and Li, Shuhua and Zhou, Jianwen and Wei, Lihong and Fu, Tongze and Liu, Bixia and Chen, Honglei and Tang, Kejing and Ke, Zunfu},
  title = {Identification of a DNA-methylome-based signature for prognosis prediction in driver gene-negative lung adenocarcinoma},
  journal = {Cancer Letters},
  year = {2024},
  doi = {10.1016/j.canlet.2024.216835}
}
Kostenlos starten →